查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1178025

妊娠毒血症诊断的全球市场:各检验类型(血液检验，尿液检查，其他)，各类产品·服务(设备，试剂·消耗品，服务)-产业分析，市场规模，占有率，成长，趋势，预测(2022年～2031年)

Preeclampsia Diagnostics Market (Test Type: Blood Test, Urine Test, and Others; Product & Services: Instruments, Reagents & Consumables, and Services) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
出版日期: | 出版商: Transparency Market Research | 英文 176 Pages | 商品交期: 2-10个工作天内

价格

本报告提供全球妊娠毒血症诊断市场相关调查分析，提供市场概要，市场分析，竞争情形等系统性资讯。

目录

第1章 序文

第2章 前提与调查手法

第3章 摘要整理:全球妊娠毒血症诊断市场

第4章 市场概要

  • 简介
    • 市场区隔定义
  • 概要
  • 市场动态
    • 促进因素
    • 阻碍因素
    • 机会
  • 全球妊娠毒血症诊断市场分析与预测(2017年～2031年)
    • 市场收益预测(100万美元)

第5章 主要洞察

  • 技术的进步
  • 全球主要国家的疾病的得病率和发生率
  • 法规情势:地区/世界
  • 主要的产业活动(合併，收购，伙伴关係，合作等)
  • COVID-19疫情对产业带来的影响

第6章 全球妊娠毒血症诊断市场分析与预测:各检验类型

  • 简介和定义
  • 主要调查结果/开发
  • 市场金额预测(2017年～2031年):各检验类型
    • 血液检验
    • 尿液检查
    • 其他
  • 市场魅力:各检验类型

第7章 全球妊娠毒血症诊断市场分析与预测:各类产品·服务

  • 简介和定义
  • 主要调查结果/开发
  • 市场金额预测(2017年～2031年):各类产品·服务
    • 设备
    • 试剂·消耗品
    • 服务
  • 市场魅力:各类产品·服务

第8章 全球妊娠毒血症诊断市场分析与预测:各终端用户

  • 简介和定义
  • 主要调查结果/开发
  • 市场金额预测(2017年～2031年):各终端用户
    • 医院
    • 诊断中心
    • 其他
  • 市场魅力:各终端用户

第9章 全球妊娠毒血症诊断市场分析与预测:各地区

  • 主要调查结果
  • 市场金额预测:各地区
    • 北美
    • 欧洲
    • 亚太地区
    • 南美
    • 中东·非洲
  • 市场魅力:各国各地区

第10章 北美的妊娠毒血症诊断市场分析与预测

第11章 欧洲的妊娠毒血症诊断市场分析与预测

第12章 亚太地区的妊娠毒血症诊断市场分析与预测

第13章 南美的妊娠毒血症诊断市场分析与预测

第14章 中东及非洲的妊娠毒血症诊断市场分析与预测

第15章 竞争情形

  • 市场参与企业:竞争矩阵(各等级及各企业规模)
  • 企业简介
    • Abbott Laboratories
    • Danaher Corporation(Beckman Coulter, Inc.)
    • Siemens Healthineers AG
    • Cardinal Health
    • F. Hoffmann-La Roche Ltd.
    • Bio-Rad Laboratories, Inc.
    • ARKRAY, Inc.
    • Sera Prognostics
    • Metabolomic Diagnostics Ltd.
    • Diabetomics, Inc.
    • ACON Laboratories, Inc.
    • DIRUI Industrial Co., Ltd.
Product Code: TMRGL32423

TMR's report on the global preeclampsia diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global preeclampsia diagnostics market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global preeclampsia diagnostics market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the preeclampsia diagnostics market.

The report delves into the competitive landscape of the global preeclampsia diagnostics market. Key players operating in the global preeclampsia diagnostics market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global preeclampsia diagnostics market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Preeclampsia Diagnostics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Preeclampsia Diagnostics Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Technological Advancements
  • 5.2. Disease Prevalence & Incidence Rate globally with key countries
  • 5.3. Regulatory Scenario by Region/globally
  • 5.4. Key Industry Events (Mergers, Acquisitions, Partnerships, Collaborations, etc.)
  • 5.5. COVID-19 Pandemic Impact on Industry

6. Global Preeclampsia Diagnostics Market Analysis and Forecast, by Test Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Test Type, 2017-2031
    • 6.3.1. Blood Test
    • 6.3.2. Urine Test
    • 6.3.3. Others
  • 6.4. Market Attractiveness By Test Type

7. Global Preeclampsia Diagnostics Market Analysis and Forecast, by Product & Services

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Product & Services, 2017-2031
    • 7.3.1. Instruments
    • 7.3.2. Reagents & Consumables
    • 7.3.3. Services
  • 7.4. Market Attractiveness By Product & Services

8. Global Preeclampsia Diagnostics Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by End-user, 2017-2031
    • 8.3.1. Hospitals
    • 8.3.2. Diagnostic Centers
    • 8.3.3. Others
  • 8.4. Market Attractiveness By End-user

9. Global Preeclampsia Diagnostics Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness By Country/Region

10. North America Preeclampsia Diagnostics Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Test Type, 2017-2031
    • 10.2.1. Blood Test
    • 10.2.2. Urine Test
    • 10.2.3. Others
  • 10.3. Market Value Forecast, by Product & Services, 2017-2031
    • 10.3.1. Instruments
    • 10.3.2. Reagents & Consumables
    • 10.3.3. Services
  • 10.4. Market Value Forecast, by End-user, 2017-2031
    • 10.4.1. Hospitals
    • 10.4.2. Diagnostic Centers
    • 10.4.3. Others
  • 10.5. Market Value Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Test Type
    • 10.6.2. By Product & Services
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Preeclampsia Diagnostics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Test Type, 2017-2031
    • 11.2.1. Blood Test
    • 11.2.2. Urine Test
    • 11.2.3. Others
  • 11.3. Market Value Forecast, by Product & Services, 2017-2031
    • 11.3.1. Instruments
    • 11.3.2. Reagents & Consumables
    • 11.3.3. Services
  • 11.4. Market Value Forecast, by End-user, 2017-2031
    • 11.4.1. Hospitals
    • 11.4.2. Diagnostic Centers
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by Country/Sub-Region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Test Type
    • 11.6.2. By Product & Services
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-Region

12. Asia Pacific Preeclampsia Diagnostics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Test Type, 2017-2031
    • 12.2.1. Blood Test
    • 12.2.2. Urine Test
    • 12.2.3. Others
  • 12.3. Market Value Forecast, by Product & Services, 2017-2031
    • 12.3.1. Instruments
    • 12.3.2. Reagents & Consumables
    • 12.3.3. Services
  • 12.4. Market Value Forecast, by End-user, 2017-2031
    • 12.4.1. Hospitals
    • 12.4.2. Diagnostic Centers
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by Country/Sub-Region, 2017-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Test Type
    • 12.6.2. By Product & Services
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-Region

13. Latin America Preeclampsia Diagnostics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Test Type, 2017-2031
    • 13.2.1. Blood Test
    • 13.2.2. Urine Test
    • 13.2.3. Others
  • 13.3. Market Value Forecast, by Product & Services, 2017-2031
    • 13.3.1. Instruments
    • 13.3.2. Reagents & Consumables
    • 13.3.3. Services
  • 13.4. Market Value Forecast, by End-user, 2017-2031
    • 13.4.1. Hospitals
    • 13.4.2. Diagnostic Centers
    • 13.4.3. Others
  • 13.5. Market Value Forecast, by Country/Sub-Region, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Test Type
    • 13.6.2. By Product & Services
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-Region

14. Middle East & Africa Preeclampsia Diagnostics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Test Type, 2017-2031
    • 14.2.1. Blood Test
    • 14.2.2. Urine Test
    • 14.2.3. Others
  • 14.3. Market Value Forecast, by Product & Services, 2017-2031
    • 14.3.1. Instruments
    • 14.3.2. Reagents & Consumables
    • 14.3.3. Services
  • 14.4. Market Value Forecast, by End-user, 2017-2031
    • 14.4.1. Hospitals
    • 14.4.2. Diagnostic Centers
    • 14.4.3. Others
  • 14.5. Market Value Forecast, by Country/Sub-Region, 2017-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Test Type
    • 14.6.2. By Product & Services
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-Region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Company Profiles
    • 15.2.1. Abbott Laboratories
      • 15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.1.2. Product Portfolio
      • 15.2.1.3. Financial Overview
      • 15.2.1.4. SWOT Analysis
      • 15.2.1.5. Strategic Overview
    • 15.2.2. Danaher Corporation (Beckman Coulter, Inc.)
      • 15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.2.2. Product Portfolio
      • 15.2.2.3. Financial Overview
      • 15.2.2.4. SWOT Analysis
      • 15.2.2.5. Strategic Overview
    • 15.2.3. Siemens Healthineers AG
      • 15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.3.2. Product Portfolio
      • 15.2.3.3. Financial Overview
      • 15.2.3.4. SWOT Analysis
      • 15.2.3.5. Strategic Overview
    • 15.2.4. Cardinal Health
      • 15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.4.2. Product Portfolio
      • 15.2.4.3. Financial Overview
      • 15.2.4.4. SWOT Analysis
      • 15.2.4.5. Strategic Overview
    • 15.2.5. F. Hoffmann-La Roche Ltd.
      • 15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.5.2. Product Portfolio
      • 15.2.5.3. Financial Overview
      • 15.2.5.4. SWOT Analysis
      • 15.2.5.5. Strategic Overview
    • 15.2.6. Bio-Rad Laboratories, Inc.
      • 15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.6.2. Product Portfolio
      • 15.2.6.3. Financial Overview
      • 15.2.6.4. SWOT Analysis
      • 15.2.6.5. Strategic Overview
    • 15.2.7. ARKRAY, Inc.
      • 15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.7.2. Product Portfolio
      • 15.2.7.3. Financial Overview
      • 15.2.7.4. SWOT Analysis
      • 15.2.7.5. Strategic Overview
    • 15.2.8. Sera Prognostics
      • 15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.8.2. Product Portfolio
      • 15.2.8.3. Financial Overview
      • 15.2.8.4. SWOT Analysis
      • 15.2.8.5. Strategic Overview
    • 15.2.9. Metabolomic Diagnostics Ltd.
      • 15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.9.2. Product Portfolio
      • 15.2.9.3. Financial Overview
      • 15.2.9.4. SWOT Analysis
      • 15.2.9.5. Strategic Overview
    • 15.2.10. Diabetomics, Inc.
      • 15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.10.2. Product Portfolio
      • 15.2.10.3. Financial Overview
      • 15.2.10.4. SWOT Analysis
      • 15.2.10.5. Strategic Overview
    • 15.2.11. ACON Laboratories, Inc.
      • 15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.11.2. Product Portfolio
      • 15.2.11.3. Financial Overview
      • 15.2.11.4. SWOT Analysis
      • 15.2.11.5. Strategic Overview
    • 15.2.12. DIRUI Industrial Co., Ltd.
      • 15.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.12.2. Product Portfolio
      • 15.2.12.3. Financial Overview
      • 15.2.12.4. SWOT Analysis
      • 15.2.12.5. Strategic Overview

List of Tables

  • Table 01: Global Preeclampsia Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 02: Global Preeclampsia Diagnostics Market Value (US$ Mn) Forecast, by Product & Services, 2017-2031
  • Table 03: Global Preeclampsia Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 04: Global Preeclampsia Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America Preeclampsia Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 06: North America Preeclampsia Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 07: North America Preeclampsia Diagnostics Market Value (US$ Mn) Forecast, by Product & Services, 2017-2031
  • Table 08: North America Preeclampsia Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 09: Europe Preeclampsia Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Europe Preeclampsia Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 11: Europe Preeclampsia Diagnostics Market Value (US$ Mn) Forecast, by Product & Services, 2017-2031
  • Table 12: Europe Preeclampsia Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Asia Pacific Preeclampsia Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Asia Pacific Preeclampsia Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 15: Asia Pacific Preeclampsia Diagnostics Market Value (US$ Mn) Forecast, by Product & Services, 2017-2031
  • Table 16: Asia Pacific Preeclampsia Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 17: Latin America Preeclampsia Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Latin America Preeclampsia Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 19: Latin America Preeclampsia Diagnostics Market Value (US$ Mn) Forecast, by Product & Services, 2017-2031
  • Table 20: Latin America Preeclampsia Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Middle East & Africa Preeclampsia Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Middle East & Africa Preeclampsia Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 23: Middle East & Africa Preeclampsia Diagnostics Market Value (US$ Mn) Forecast, by Product & Services, 2017-2031
  • Table 24: Middle East & Africa Preeclampsia Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Preeclampsia Diagnostics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Preeclampsia Diagnostics Market Value Share, by Test Type, 2021
  • Figure 03: Preeclampsia Diagnostics Market Value Share, By Product & Services, 2021
  • Figure 04: Preeclampsia Diagnostics Market Value Share, by End-user 2021
  • Figure 05: Global Preeclampsia Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 06: Global Preeclampsia Diagnostics Market Attractiveness Analysis, by Test Type, 2022-2031
  • Figure 07: Global Preeclampsia Diagnostics Market Value (US$ Mn), by Blood Test, 2017-2031
  • Figure 08: Global Preeclampsia Diagnostics Market Value (US$ Mn), by Urine Test, 2017-2031
  • Figure 09: Global Preeclampsia Diagnostics Market Value (US$ Mn), by Others, 2017-2031
  • Figure 10: Global Preeclampsia Diagnostics Market Value Share Analysis, By Product & Services, 2021 and 2031
  • Figure 11: Global Preeclampsia Diagnostics Market Attractiveness Analysis, By Product & Services, 2022-2031
  • Figure 12: Global Preeclampsia Diagnostics Market Revenue (US$ Mn), by Instruments, 2017-2031
  • Figure 13: Global Preeclampsia Diagnostics Market Revenue (US$ Mn), by Reagents & Consumables, 2017-2031
  • Figure 14: Global Preeclampsia Diagnostics Market Revenue (US$ Mn), by Services, 2017-2031
  • Figure 15: Global Preeclampsia Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 16: Global Preeclampsia Diagnostics Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 17: Global Preeclampsia Diagnostics Market Revenue (US$ Mn), by Hospitals, 2017-2031
  • Figure 18: Global Preeclampsia Diagnostics Market Revenue (US$ Mn), by Diagnostic Centers, 2017-2031
  • Figure 19: Global Preeclampsia Diagnostics Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 20: Global Preeclampsia Diagnostics Market Value Share Analysis, by Region, 2021 and 2031
  • Figure 21: Global Preeclampsia Diagnostics Market Attractiveness Analysis, by Region, 2022-2031
  • Figure 22: North America Preeclampsia Diagnostics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 23: North America Preeclampsia Diagnostics Market Value Share Analysis, by Country, 2021 and 2031
  • Figure 24: North America Preeclampsia Diagnostics Market Attractiveness Analysis, by Country, 2022-2031
  • Figure 25: North America Preeclampsia Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 26: North America Preeclampsia Diagnostics Market Attractiveness Analysis, by Test Type, 2022-2031
  • Figure 27: North America Preeclampsia Diagnostics Market Value Share Analysis, By Product & Services, 2021 and 2031
  • Figure 28: North America Preeclampsia Diagnostics Market Attractiveness Analysis, By Product & Services, 2022-2031
  • Figure 29: North America Preeclampsia Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 30: North America Preeclampsia Diagnostics Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 31: Europe Preeclampsia Diagnostics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 32: Europe Preeclampsia Diagnostics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 33: Europe Preeclampsia Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 34: Europe Preeclampsia Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 35: Europe Preeclampsia Diagnostics Market Attractiveness Analysis, by Test Type, 2022-2031
  • Figure 36: Europe Preeclampsia Diagnostics Market Value Share Analysis, By Product & Services, 2021 and 2031
  • Figure 37: Europe Preeclampsia Diagnostics Market Attractiveness Analysis, By Product & Services, 2022-2031
  • Figure 38: Europe Preeclampsia Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 39: Europe Preeclampsia Diagnostics Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 40: Asia Pacific Preeclampsia Diagnostics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 41: Asia Pacific Preeclampsia Diagnostics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 42: Asia Pacific Preeclampsia Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 43: Asia Pacific Preeclampsia Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 44: Asia Pacific Preeclampsia Diagnostics Market Attractiveness Analysis, by Test Type, 2022-2031
  • Figure 45: Asia Pacific Preeclampsia Diagnostics Market Value Share Analysis, By Product & Services, 2021 and 2031
  • Figure 46: Asia Pacific Preeclampsia Diagnostics Market Attractiveness Analysis, By Product & Services, 2022-2031
  • Figure 47: Asia Pacific Preeclampsia Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 48: Asia Pacific Preeclampsia Diagnostics Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 49: Latin America Preeclampsia Diagnostics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 50: Latin America Preeclampsia Diagnostics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 51: Latin America Preeclampsia Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 52: Latin America Preeclampsia Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 53: Latin America Preeclampsia Diagnostics Market Attractiveness Analysis, by Test Type, 2022-2031
  • Figure 54: Latin America Preeclampsia Diagnostics Market Value Share Analysis, By Product & Services, 2021 and 2031
  • Figure 55: Latin America Preeclampsia Diagnostics Market Attractiveness Analysis, By Product & Services, 2022-2031
  • Figure 56: Latin America Preeclampsia Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 57: Latin America Preeclampsia Diagnostics Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 58: Middle East & Africa Preeclampsia Diagnostics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 59: Middle East & Africa Preeclampsia Diagnostics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 60: Middle East & Africa Preeclampsia Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 61: Middle East & Africa Preeclampsia Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 62: Middle East & Africa Preeclampsia Diagnostics Market Attractiveness Analysis, by Test Type, 2022-2031
  • Figure 63: Middle East & Africa Preeclampsia Diagnostics Market Value Share Analysis, By Product & Services, 2021 and 2031
  • Figure 64: Middle East & Africa Preeclampsia Diagnostics Market Attractiveness Analysis, By Product & Services, 2022-2031
  • Figure 65: Middle East & Africa Preeclampsia Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 66: Middle East & Africa Preeclampsia Diagnostics Market Attractiveness Analysis, by End-user, 2022-2031